Company page
Hansa Biopharma Ab
Hansa Biopharma AB is a public company listed on the Swedish market under the ticker HNSA, with a market capitalization of approximately 346 million USD. The company focuses on developing innovative therapies for patients with rare diseases. Hansa Biopharma aims to address significant unmet medical needs through its research and development efforts.
- Ticker
- HNSA:OMXSTO
- Asset type
- Stock
- Market cap
- $346.1M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- OMXSTO
- Currency
- SEK